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were compared with changes in BMI in those free of dementia.
Methods: A total of 10,308 adults (33% women) aged 35 to 55 years in 1985 were followed up until
2015. BMI was assessed six times and 329 cases of dementia were recorded.
Results: Obesity (BMI30 kg/m2) at age 50 years (hazard ratio5 1.93; 1.35–2.75) but not at 60 or
70 years was associated with risk of dementia. Trajectories of BMI differed in those with dementia
compared with all others (P , .0001) or to matched control subjects (P , .0001) such that BMI in
dementia cases was higher from 28 years (P5 .001) to 16 years (P5 .05) and lower starting 8 years
before diagnosis.
Discussion: Obesity in midlife and weight loss in the preclinical phase characterizes dementia; the
current obesity epidemic may affect future dementia rates.
 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Keywords: Obesity; BMI; Dementia; Waist circumference; Waist-to-hip ratio1. Introduction
Prospective studies, particularly those with extended
follow-up [1], suggest midlife obesity is a risk factor for de-
mentia [2–5]. Meta-analyses and systematic reviews show
the excess risk to be similar for Alzheimer’s disease and
all-cause dementia [6–8], with effects being stronger in
studies with a follow-up longer than 10 years, and when
body mass index (BMI) is assessed before age 60 years [6].
The hypothesis that midlife obesity increases risk for de-
mentia has been challenged by two sets of recent findings.
The first using electronic patient records from 2 million
adults showed lower rates of dementia in the obese and pro-t: The authors have no conflicts of interest to declare.
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ns.org/licenses/by/4.0/).gressively decreasing risk with increasing obesity [9]. As
previous meta-analyses suggesting midlife obesity to be a
risk factor for dementia are based on less than 50,000 per-
sons overall [2,6,7], inclusion of this new study in future
meta-analyses would undoubtedly change conclusions.
The second set of studies was based on aMendelian random-
ization (MR) approach, which uses genetic variants as prox-
ies for exposures, to show no association between obesity
and dementia [10,11]. These findings taken together raise
questions about the inclusion of midlife obesity in
guidelines for dementia prevention, such as the one
published last year [12].
BMI in older adults with dementia is typically lower than
age peers, with weight loss starting 10 years or more before
clinical onset [13]. Pathophysiological processes underlying
dementia are known to span several years, perhaps decades
[14,15], and may lead to weight loss before disease onset
[16]. However, the BMI trajectory in those with dementiaeimer’s Association. This is an open access article under the CC BY license
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BMI data over the adult life course show those with demen-
tia to gain less weight [17], or experience accelerated weight
loss in old age [13,18], but no differences in BMI in midlife.
The inconsistencies are likely to be because of the analysis
of change in BMI being anchored by wave of BMI
assessment rather than the etiologic stage of dementia.
We use an innovative analytic approach with two objec-
tives. First, to understand when in midlife obesity carries
risk for dementia, we model the risk associated with obesity
at ages 50, 60, and 70 years. This is in contrast to studies that
used a wide age range and adjusted for age to make infer-
ences about the effect of “midlife” obesity. Our method al-
lows better insight into the manner in which age modifies
the association between obesity and dementia. Second, to
study changes in BMI, we use repeat data and model trajec-
tories of BMI for more than 28 years, using a backward time-
scale anchored to the year of dementia diagnosis. This
method allows BMI differences between dementia cases
and those free of dementia to be estimated for each of the
28 years preceding dementia diagnosis. Analyses were
repeated with waist circumference and waist-to-hip ratio to
determine whether their associations with dementia are
similar to that obtained for BMI.2. Methods
2.1. Study design and participants
The Whitehall II study is an ongoing cohort study of men
and women originally employed by the British civil service
in London-based offices [19]. A total of 10,308 persons
(6895 men and 3413 women, aged 35–55) were recruited
in the study from the years 1985 to 1988, with a response
rate of 73%. Since the baseline medical examination,
follow-up examinations have taken place approximately
every 5 years. Data collection involves a postal questionnaire
(health behaviors, psychosocial factors, and mental health)
and a medical examination undertaken by trained nurses us-
ing a standard protocol at a central London clinic or at home
for those unable/unwilling to travel. Written informed con-
sent from participants and research ethics approvals were re-
newed at each contact; the most recent approval was from the
University College London Hospital Committee on the
Ethics of Human Research, reference number 85/0938.
2.2. Measurement of adiposity
We obtained data for BMI (weight in kilograms/height in
meters squared) from study baseline 1985 to 1988 and all
subsequent clinical assessments; flow chart of study is pre-
sented in Supplementary Fig. 1. Weight was measured in un-
derwear to the nearest 0.1 kg on Soehnle electronic scales
with digital readout (Leifheit AS, Nassau, Germany). Height
was measured in bare feet to the nearest 1 mm using a stadi-
ometer with the participant standing erect with head in the
Frankfurt plane. The World Health Organization classifica-tion was used to categorize BMI as ,18.5 kg/m2 (under-
weight), 18.5 to 24.99 kg/m2 (normal weight), 25 to
29.99 kg/m2 (overweight), and 30 kg/m2 (obese) [20].
Waist and hip circumferences, starting at the 1991 to 1993
assessment, were measured with subjects in the standing po-
sition in light clothing, using a fiberglass tape measure at
600 g tension.Waist circumference was taken as the smallest
circumference at or below the costal margin and hip circum-
ference at the level of the greater trochanter. Waist circum-
ference categories were small (94/80 cm in men/
women), intermediate (94 to 102/80 to 88 cm in men/
women), and large (102/88 cm in men/women) [21]. For
waist-to-hip ratio, we used values 1.0 in men and 0.85 in
women to denote obesity [22].2.3. Dementia
We used comprehensive tracing of electronic health re-
cords for dementia ascertainment using three databases: the
national hospital episode statistics database, the Mental
Health Services Data Set, and the national mortality register.
The National Health Service in the UK uses in-house codes
mapped onto International Classification of Diseases-10 co-
des for dementia. The National Health Service provides
most of the health care; hospital episode statistics andMental
Health ServicesData Set are national databaseswith informa-
tion on both inpatient and outpatient care, with the latter also
including data on care in the community. Record linkage until
March 31, 2015 identified 329 cases of dementia, 176 cases
were first recorded in the hospitalization register, 145 in the
mental health register, and eight in the mortality register.
The validity of dementia cases in our study is supported
by modeling changes in the global cognitive score,
composed of tests of memory, reasoning, and phonemic
and semantic fluency administered to the participants in
1997, 2003, 2007, and 2012 [23]. These results show accel-
erated decline in global cognitive score in the 8 to 10 years
before dementia diagnosis (Supplementary Fig. 2) as has
been shown in studies that use a “gold-standard” dementia
ascertainment procedure [24].2.4. Covariates
Education was reported by the participant as the highest
level of education achieved and regrouped into five standard
hierarchic levels: no formal education, lower secondary ed-
ucation, higher secondary education, university degree, and
higher university degree.
Cardiovascular disease (CVD), diabetes, and medication:
ascertainment of these conditions was based on two methods:
study specific assessments (1985, 1989, 1991, 1997, 2001,
2003, 2006, 2007, and 2012) and linkage to electronic health
records for nonresponders and chronic conditions occurring
between study waves. A 12-lead resting electrocardiogram
recording, coded using the Minnesota system, was used for
coronary heart disease. Stroke assessment was based on the
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CArdiovascular disease (MONICA)-Ausburg strokequestion-
naire, corroborated in medical records. Diabetes was deter-
mined by fasting glucose 7.0 mmol/L, reported doctor-
diagnosed diabetes, or use of diabetesmedication.Medication
for CVD was reported by the participants at each wave.2.5. Statistical analysis
We undertook two sets of analyses; first, Cox regression
to examine associations of adiposity measures at ages 50,
60, and 70 years (three separate models) with subsequent de-
mentia. Analyses were based on all participants with data on
obesity, follow-up for dementia commencing on the date of
the obesity measure. Second, we compared changes in BMI
(trajectories) in those with dementia with other participants
using a backward timescale. The trajectory analysis was
repeated using a case (dementia cases, n5 329) and control
(n 5 1974) design to better control for the confounding ef-
fects of age, sex, education, and period effects in measures
of BMI and dementia.
2.5.1. Analysis 1: associations of adiposity at ages 50, 60,
and 70 years with dementia and mortality
Age ranges of the participants at the six clinical evaluations
between 1985 to 1988 and 2012 to 2013 were 35 to 55, 40 to
64, 45 to 69, 50 to 74, 55 to 79, and 60 to 84 years. We ex-
tracted data on adipositymeasures at ages 50, 60, and 70 years
for each participant across the data waves. For example, a
participant who was 50 years old at the first clinical assess-
ment (1985–1988) contributed to the analysis (and person
years of follow-up) for “BMI at age 50” using data from the
first wave, the analyses for “BMI at age 60” using data from
the third clinic (1997–1999), and “BMI at age 70” using
data from the fifth clinic (2007–2009). The analyseswere first
runwith dementia as an outcome and repeatedwithmortality;
both using Cox regression with date of entry being the date of
clinical assessment fromwhich the obesity measure (separate
models for age 50, 60, and 70 years) was drawn. In the anal-
ysis for dementia, those who died free of dementia were
censored at death so that participants were followed until
the record of dementia, death, or March 31, 2015, whichever
came first. For analysis of mortality, they were followed until
the record of death or March 31, 2015, whichever came first.
All analyseswere adjusted for age, sex, and education. InSup-
plementary Tables, we show analyses with further adjustment
for diabetes, CVD, and medication for these conditions.
2.5.2. Analysis 2: trajectories of adiposity before dementia
Trajectories of BMI for more than 28 years were modeled
using a backward timescale such that year 0 was year of de-
mentia for dementia cases, year of death for those who died
during the follow-up, andMarch 31, 2015 (end of follow-up)
for all others. BMI in each of the preceding 28 years (years
0 to228) was estimated from mixed effects models with the
intercept and slope as random effects and a backward time-scale [24]. Dementia (coded as 1 for cases and 0 for others)
and its interaction with time and time squared (to allow for
nonlinear change) were added to the model to test for differ-
ences in BMI trajectories between cases and others. This
modeling strategy implies that year 0 (the index date) was
the intercept in the analysis and the beta associated with
the dementia term yielded the difference in BMI between
cases and others/control subjects at dementia diagnosis.
The slope terms (time and time squared) allow the assess-
ment of changes in BMI for more than the previous 28 years.
To test whether these were different in cases and others, we
examined whether the terms dementia ! time and
dementia! time squared improved the fit of the model us-
ing the Wald test. Analyses were adjusted for age, sex, edu-
cation, their interactions with time and time squared, and for
5-year birth cohort to take cohort effects into account.
These analyses on BMI trajectories anchored to the year
of dementia diagnosis were repeated using a case-control
approach to account for period effects in measures of BMI
and dementia. Year 0 for both cases and control subjects
was the year of dementia diagnosis. Each case was individ-
ually matched to six control subjects drawn randomly from
the study population using the following criteria: age (5-year
age group at the index year), sex, education (university de-
gree or not), being alive at year 0, and without a diagnosis
of dementia at the end of follow-up. The case-control ana-
lyses were also undertaken for waist circumference and
waist-to-hip ratio on the same cases and control subjects,
albeit with a shorter follow-up of 22 years.
The software SAS 9.4 (SAS Institute, NC, USA) was used
for data management and STATA 14 (StataCorp LP, College
Station, TX, USA) for analysis. A two-sided P value ,.05
was considered statistically significant.3. Results
Themean (standard deviation) age of thosewith dementia
(N 5 329) was 75.0 (5.4) years and those who died
(N5 1653) was 67.6 (9.4) years. Cases of dementia accrued
between 1995 and 2015, with 73% of cases recorded in the
last 5 years of follow-up. Increasing age (hazard ratio [HR]
for 1 year greater age at study baseline associated with a
1.21; 95% confidence interval, 1.19–1.24), female sex
(HR 5 1.58; 1.27–1.96), and education less than secondary
school diploma (HR 5 1.76; 1.41–2.19) were associated
with higher risk of dementia. Table 1 presents study charac-
teristics as a function of dementia status in the total popula-
tion and in cases and control subjects. BMI in those with
dementia was higher at age 50 years (P  .01) but not
different from thosewithout dementia at age 60 and 70 years.3.1. Associations of adiposity at ages 50, 60, and 70 years
with dementia and mortality
A total of 10.9% of participants were obese at age 50,
17.1% at age 60, and 18.7% at age 70 years (Table 2).
Table 1
Sample characteristics by dementia status at the end of follow-up
Characteristics
Total population Case-control design
Dementia No dementia P value Dementia No dementia P value
N 329 9974 329 1974
Age at baseline, M (SD) 50.5 (4.5) 44.8 (6.0) ,.0001 50.5 (4.5) 49.2 (4.9) ,.0001
Sex, N (%) women 144 (43.8) 3267 (32.8) ,.0001 144 (43.8) 864 (43.8) 1
Education, N (%)
No 52 (15.8) 977 (9.8) ,.0001 52 (15.8) 337 (17.1) .21
Primary 146 (44.4) 3722 (37.3) 146 (44.4) 767 (38.9)
A level 68 (20.7) 2675 (26.8) 68 (20.7) 492 (24.9)
University or higher 63 (19.2) 2600 (26.1) 63 (19.2) 378 (19.2)
Mean follow-up, M (SD) 24.5 (3.5) 26.7 (4.5) ,.0001 24.5 (3.5) 28.6 (1.1) ,.0001
BMI (kg/m2), M (SD)
BMI at 50 years 26.1 (4.2) 25.5 (3.8) .01 26.1 (4.2) 25.2 (3.6) .0003
BMI at 60 years 26.4 (4.4) 26.5 (4.3) .79 26.4 (4.4) 26.1 (4.1) .32
BMI at 70 years 26.3 (4.6) 26.8 (4.4) .18 26.3 (4.6) 26.7 (4.4) .30
Abbreviations: BMI, body mass index; SD, standard deviation.
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at age 50 (HR 5 1.93; 1.35–2.75; P , .0001) but not at age
60 (HR5 1.31; 0.89–1.92; P5 .17) or 70 years (HR5 0.87;
0.56–1.34; P 5 .53). BMI 30 kg/m2, at all three ages, was
associated with greater risk of mortality. Our analyses were
underpowered to examine the impact of underweight (BMI
,18.5 kg/m2) on dementia but suggested increased risk of
mortality in all age groups. Further adjustment for CVD, dia-
betes, and CVD medication did not alter these results
(Supplementary Table 1). Analyses of waist circumference
and waist-to-hip ratio are shown in Supplementary Tables 2
and 3 in the minimally and fully adjusted models. There
was some evidence of an association between a large waist
circumference at age 50 years and dementia (HR 5 1.80;
0.98–3.33; P 5 .06) but not at ages 60 and 70 years
(Supplementary Table 2); waist-to-hip ratio was not associ-
ated with dementia.Table 2
Association of BMI at ages 50, 60, and 70 years with subsequent dementia and m
BMI
Dementia
N cases/N HR (95% CI) P
BMI at 50 years
,18.5 kg/m2 1/72 0.51 (0.07–3.63)
18.5–24.9 kg/m2 128/4208 1.00 R
25–29.9 kg/m2 104/3219 1.18 (0.91–1.52)
30 kg/m2 42/913 1.93 (1.35–2.75) ,
BMI at 60 years
,18.5 kg/m2 0/63 NA
18.5–24.9 kg/m2 98/2819 1 R
25–29.9 kg/m2 96/3162 1.02 (0.77–1.36)
30 kg/m2 38/1246 1.31 (0.89–1.92)
BMI at 70 years
,18.5 kg/m2 2/39 1.89 (0.46–7.81)
18.5–24.9 kg/m2 72/1731 1.00 R
25–29.9 kg/m2 57/2159 0.61 (0.43–0.87)
30 kg/m2 30/904 0.87 (0.56–1.34)
Abbreviations: BMI, body mass index; CI, confidence interval; HR, hazard rati
*Analyses adjusted for age, sex, and education.3.2. Trajectories of adiposity before dementia
The trajectory of BMI formore than 28 years was different
(P, .0001) in those with dementia compared with all nonde-
mented participants (Fig. 1A), the differences in BMI be-
tween these two groups are presented in Table 3. These
results, using a backward timescale, showed that those with
dementia had higher BMI in midlife and accelerated decline
in the decade before dementia diagnosis. Analyses with the
backward timescalewere repeated using a case-control design
(Fig. 1B). These analyses also show BMI trajectories to be
different in cases and control subjects (P , .0001). In cases
BMI was higher in midlife and they experienced accelerated
decline inBMI in theyears before dementia.BMI in caseswas
significantly higher from year 228 (0.79, P 5 .001) to year
216 (0.47 kg/m2, P 5 .05), starting from year 28 BMI was
lower in cases than in control subjects (Table 3).ortality*
Mortality
value N cases/N HR (95% CI) P value
.50 13/72 1.40 (0.81–2.43) .23
ef 611/4208 1.00 Ref
.22 505/3219 1.12 (0.99–1.26) .06
.0001 176/913 1.63 (1.38–1.94) ,.0001
12/63 2.51 (1.41–4.48) .002
ef 343/2819 1.00 Ref
.87 388/3162 1.13 (0.97–1.30) .11
.17 169/1246 1.53 (1.27–1.85) ,.0001
.37 6/39 2.54 (1.12–5.79) .03
ef 166/1734 1.00 Ref
.006 196/2160 0.93 (0.76–1.15) .52
.53 102/907 1.42 (1.10–1.82) .007
o; SD, standard deviation.
Fig. 1. Trajectories of BMI in the 28 years before dementia. (1) The figure represents marginal effects of dementia on trajectories of BMI, adjusted for age, sex,
and education and 5-year birth cohort in panel (A). Mean number of observations per participant is 3.3 for dementia cases and 4.1 for those dementia free for
approach (A) and 4.4 for control subjects for approach (B). (2) The 95% confidence intervals are presented for alternate time points for ease of presentation.
Table 3
Differences in BMI between cases and the others and between cases and
control subjects for more than the 28 years before dementia*
Year
Dementia cases compared
with all others
Dementia cases compared
with matched control
subjects
Difference in BMI P value Difference in BMI P value
228 0.69 .002 0.79 .001
227 0.64 .002 0.78 .001
226 0.60 .004 0.77 .001
225 0.56 .007 0.76 .001
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more than the 22 years to differ in cases and control subjects
(P , .0001); yearly differences in waist circumference are
tabulated in Supplementary Table 4. Waist circumference in
those with dementia was higher from year 222 (1.64 cm,
P5.04) to year216 (1.46,P5.04) and lower starting 8 years
before dementia. Fig. 2 (Panel B) shows a similar pattern of
results for waist-to-hip ratio (Supplementary Table 4 pro-
vides yearly differences), with the trajectories in those with
dementia being different from the control subjects
(P 5 .0009) and rapid decline close to dementia diagnosis.224 0.52 .01 0.74 .001
223 0.47 .02 0.72 .001
222 0.43 .04 0.70 .002
221 0.39 .07 0.67 .003
220 0.35 .11 0.64 .005
219 0.30 .16 0.60 .009
218 0.26 .24 0.56 .02
217 0.22 .33 0.52 .03
216 0.17 .45 0.47 .05
215 0.13 .57 0.42 .08
214 0.09 .71 0.37 .14
213 0.05 .85 0.31 .22
212 0.00 .99 0.25 .33
211 20.04 .88 0.18 .48
210 20.08 .75 0.11 .67
29 20.12 .63 0.04 .89
28 20.17 .53 20.04 .88
27 20.21 .44 20.12 .66
26 20.25 .36 20.20 .47
25 20.30 .30 20.29 .31
24 20.34 .24 20.38 .19
23 20.38 .20 20.48 .11
22 20.42 .17 20.58 .06
21 20.47 .14 20.68 .04
0 20.51 .12 20.79 .02
Abbreviation: BMI, body mass index.
*All analyses adjusted for age, sex, education; analyses also adjusted for
their interaction with time and time squared, when P , .05.4. Discussion
Results from the Whitehall II study of more than 10,000
men and women with repeat BMI assessments for more than
28 years show that obesity (BMI 30 kg/m2) at age 50 years
is a risk factor for dementia. This associationwasgreatly atten-
uated when BMI was assessed at ages 60 and 70 years. These
findings were corroborated in analysis of trajectories where
BMI differences between those with dementia and those free
of dementiawere examined for each of the 28 years preceding
dementia diagnosis. Taken together, the present data demon-
strate that the association between obesity and dementia is
modified by age at obesity measurement, such that midlife
obesity is a risk factor for dementia but BMI begins to decline
in those with dementia in the years before diagnosis.
Data from several studies show increased dementia risk
with midlife obesity [1,3,4,25–29], these are reflected in
conclusions of meta-analyses [2,6,7]. However, a recent
large-scale study found obesity to be protective, with the risk
of obesity decreasing with increasing levels of obesity such
that those in class III obesity (BMI 40 kg/m2) had 29%
(95% confidence interval 22–36) lower risk of dementia than
Fig. 2. Trajectories of waist circumference (A) and waist-to-hip ratio (B) in the 22 years before dementia. Note: (1) The figure represents marginal effects of
dementia on trajectories of waist circumference and waist-to-hip ratio, adjusted for age, sex, and education. Mean number of observations per participant is 2.8
for cases and 3.4 for control subjects. (2) Confidence intervals are presented for alternate time points for ease of presentation. (3) Estimated differences in BMI at
each time point are presented in Supplementary Table 4.
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on only a third of the eligible sample because of missing data
onBMI, selection bias is likely to affect results. Furthermore, a
follow-up of less than 10 years is perhaps too short a period to
remove effects of preclinical dementia, given that changes un-
derlying dementia are known to unfold over many years [15].
In our data, use of a backward timescale on all participants
shows the BMI trajectories to intersect 12 years before the
diagnosis of dementia, this was reduced to 8 years in analysis
using a case-control design, which adjusted for covariates bet-
ter and took period effects into account.
The risk of dementia associated with obesity at older ages
is either attenuated or reversed [30]. This is possibly because
of preclinical changes inweight in theyears preceding clinical
onset of dementia [31], estimated to result in a 10% loss of to-
tal body weight [18], and observed in previous studies for
more than a period of 2 to 4 years [18], 5 years [32], or up
to 10 years [13] before diagnosis of dementia. A combination
of predementia apathy, loss of initiative, and reduced olfac-
tory function could explain this association [13]. As evidence
of the risk associatedwith highBMI inmidlife and lowBMIat
older ages comes from separate data sets, the findings onBMI
have been interpreted as being conflicting or inconsistent. At
least two previous studies used two BMI assessments, one in
midlife and the second at older ages [28,29], and both show
higher BMI in midlife and lower BMI in late life to carry
risk for dementia. Our study is the first to model BMI
trajectories for more than nearly three decades before
dementia using an analytic strategy anchored to the etiology
of disease. The advantage of this method is that the
timescale used in the analysis is years before dementia
diagnosis rather than age (which can vary between
individuals for dementia onset) or data collection cycle
(which conflates the effects of age and stage of dementia).Two recent MR studies, using overlapping data on older
adults [11,33], showed no association between obesity and
dementia. These studies might be affected by selective BMI-
related survival [33]. The AD Genetics Consortium, which
contributed the bulk of cases and control subjects to both arti-
cles, is based on cases where the mean age of dementia onset
was 74.7 years and the age of examination of control subjects
was 76.3 years. When cases and control subjects are drawn
from older adults, the MR approach is subject to “survivor”
bias [33], in this case because of higher mortality in the obese
[34]. In our data among participants born between 1930 and
1940, 24% of the obese at baseline did not reach age 75 years
compared with 15% of their normal weight counterparts.
The exact mechanisms explaining the increased risk of de-
mentia associated with obesity are poorly understood.
Obesity in midlife [35] and at older ages [36] is associated
with brain atrophy. There is also evidence suggesting a variant
of the fat mass and obesity-associated (FTO) gene affects
brain structure, causing deficits in the frontal and occipital
lobes [37,38]. Obesity is also likely to influence cognition
through its impact on vascular risk factors and pathology,
and some authors have highlighted the role of adipocyte
hormones and cytokines [16]. Genome-wide association
studies, in turn, show genetic risk variants that influence
vascular and inflammatory pathways to be associatedwith de-
mentia [39,40]. Potential avenues of further research include
brain atrophy, disruption in cerebrovascular function,
development of amyloid pathology, breakdown in the
blood-brain barrier, and systemic and neuroinflammation.
The major strength of our study is the use of BMI data
covering a period of 28 years, which allowed us to assess
both the risk associated with obesity at specific ages and
model trajectories of BMI for more than 28 years before de-
mentia onset. Our use of both BMI and other indices of
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life course allow the natural history of this relationship to be
established. The case-control design analysis strategy
ensured a better control for period effects (the effects of cal-
endar time on dementia diagnosis or adiposity) and con-
founders (age, sex, and education). The use of three
markers of obesity also allows us to conclude that BMI, the
most widely used measure because of ease of data collection,
is suitable for the assessment of risk of dementia and death.
A key limitation of our study is underascertainment of de-
mentia because of use of linkage to electronic health records.
A comparison of the passive case finding via record linkage to
an active approach in theMayo Clinic Study of Aging and the
Adult Changes reported the passive approach to have very
high specificity and sensitivity of approximately 70%,
missing mostly milder cases of dementia [41]. A similar
pattern is likely in our study because of universal health
coverage in the UK, where electronic health records have
been shown to be reliable for dementia [42]. Therewas no ev-
idence in our data that BMI affected age of dementia diag-
nosis. In analyses on BMI at 50 years the age of dementia
diagnosis was 75.62 years in normal weight participants,
75.64 years in overweight participants, and 75.85 years in
obese participants. Thus, any misclassification of dementia
status is likely to be random, that is, the probability of demen-
tia status being misclassified is independent of BMI. This
means that under conditions of high specificity, the associa-
tion between risk factor and outcome is unlikely to be biased
by underascertainment of the outcome [43]. Furthermore,
consistency in results between the survival analysis and that
using trajectories of adiposity markers suggests that these re-
sults are also robust to nonrandom misclassification. The
advantage of our passive case finding approach is that demen-
tia status was available on all participants and not only on
those who continued to participate in the study over the
follow-up, thus increasing the generalizability of findings.
Wewere unable to examine the subcategories of dementia
because of small numbers but previous reports show similar
findings for the association of obesity with dementia sub-
types [4,18,27,28,31]. Finally, the prevalence of obesity
was relatively low in this cohort and it was not possible to
undertake detailed analyses stratified by degrees of
obesity; for example, only 2.2%, 4.1%, and 5.2% of
participants were severely obese (BMI .35 kg/m2) at ages
50, 60, and 70 years, respectively.
Our findings have important implications. Considerable
improvements in cardiovascular health and education over
the second half of the last century are suggested to be respon-
sible for the leveling of the incidence rates of dementia [44].
In the past 40 years, however, there has been a startling in-
crease in the number of obese persons, rising from 105
million in 1975 to 641 million in 2014. Our results suggest
midlife obesity is a risk factor for dementia, and the extent
to which the continuing obesity epidemic will create a surge
in future dementia rates is an important public health issue.Acknowledgments
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1 Systematic review. We searched PubMed, to identify
the scientific literature on the association between
obesity and dementia. Meta-analyses, the last publi-
cation dated from 2011 (total n 5 30, 470), suggest
thatmidlife obesity is associatedwith increased risk of
dementia. However, a 2015 publication on 2 million
adults showed lower dementia risk in the obese, with
the risk decreasing with increasing obesity. Thus,
whether obesity is a risk factor for dementia is unclear
despite it being included routinely in guidelines that
aim to prevent/delay dementia.
2 Interpretation. Obesity at age 50 years but not at ages
60 and 70 years was associated with increased risk of
dementia. Natural history of body mass index (BMI),
anchored to dementia diagnosis such that changes in
BMI were modeled over 28 years preceding dementia
diagnosis, shows obesity in midlife and weight loss in
the preclinical phase to characterize BMI changes in
those with dementia.
3 Future directions. Obesity in midlife carries risk for
dementia; not accounting for the preclinical phase ex-
plains inconsistency in results from previous studies.
Our results highlight the importance of the analytic
framework used to identify putative risk factors for
dementia. The ongoing obesity epidemic may well
impact dementia incidence in the future.
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